2025
Rapid response to behavioral/pharmacological obesity treatments for binge‐eating disorder predicts better clinical outcomes
Lydecker J, Gueorguieva R, Grilo C. Rapid response to behavioral/pharmacological obesity treatments for binge‐eating disorder predicts better clinical outcomes. Obesity 2025, 33: 1067-1075. PMID: 40265670, DOI: 10.1002/oby.24292.Peer-Reviewed Original ResearchConceptsBinge-eating disorderBinge-eating remissionEating-disorder psychopathologyAssociated with greater reductionsObesity treatmentCo-occurring obesityBinge-eating frequencyClinical trial testingBehavioral therapyNon-rapid responseGreater reductionsPercent weight lossNaltrexone/bupropionRandomized clinical trial testingDisordersPrognostic significanceParticipantsPosttreatmentClinical characteristicsPrognostic indicatorClinical outcomesMetabolic outcomesResponse effectMetabolic variablesObesity interventions
2023
Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial
Grilo C, Lydecker J, Gueorguieva R. Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial. Psychological Medicine 2023, 53: 7775-7784. PMID: 37366017, PMCID: PMC10751383, DOI: 10.1017/s0033291723001800.Peer-Reviewed Original ResearchConceptsNaltrexone/bupropionBinge-eating disorderBinge-eating remissionAcute treatmentMaintenance treatmentBinge-eating frequencyDouble-blind placebo-controlled trialBehavioral weight loss therapyWeight lossCo-occurring obesitySuccessful acute treatmentPlacebo-controlled trialWeight loss therapySignificant additional weight lossSingle-site trialAdditional weight lossAcute efficacyRemission rateAdult patientsComorbid obesityBupropionInitial interventionPosttreatment assessmentRespondersPlacebo
2022
Co-occurring alcohol use disorder and obesity in U.S. military veterans: Prevalence, risk factors, and clinical features
Carr MM, Serowik KL, Na PJ, Potenza MN, Martino S, Masheb RM, Pietrzak RH. Co-occurring alcohol use disorder and obesity in U.S. military veterans: Prevalence, risk factors, and clinical features. Journal Of Psychiatric Research 2022, 150: 64-70. PMID: 35358833, DOI: 10.1016/j.jpsychires.2022.03.039.Peer-Reviewed Original ResearchConceptsAlcohol use disorderCo-occurring alcohol use disorderCo-occurring obesityU.S. military veteransRisk factorsUse disordersProbable alcohol use disorderAlcohol Use Disorders Identification TestMore adverse childhood experiencesBody mass indexMilitary veteransSelf-reported heightDisorders Identification TestAdverse childhood experiencesClinical featuresClinical presentationMass indexNeeds of veteransClinical correlatesClinical conditionsMultinomial logistic regressionObesityChildhood adversityLogistic regressionEffective interventions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply